BioNTech SE Equity And Liabilities
BioNTech SE (BNTX) had Equity And Liabilities of EUR 21.99 billion as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:EquityAndLiabilities · last filed 2026-03-10
- 2025-12-31: Equity And Liabilities 21.99B EUR.
- 2024-12-31: Equity And Liabilities 22.53B EUR.
- 2023-12-31: Equity And Liabilities 23.01B EUR.
- 2022-12-31: Equity And Liabilities 23.28B EUR.
| Period end | Equity And Liabilities | Equity And Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 21.99B EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 22.53B EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 23.01B EUR 20-F · filed 2025-03-10 | |
| 2022-12-31 | 23.28B EUR 20-F · filed 2024-03-20 | |
| 2021-12-31 | 15.83B EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 2.32B EUR 20-F/A · filed 2022-10-26 | 2.32B EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 797.65M EUR 20-F · filed 2021-03-30 | |
| 2018-12-31 | 652.99M EUR 20-F · filed 2020-03-31 |